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The toxic shock syndrome toxin I (TSST-1)' is an extracellular single chain
protein (1, 2) produced by several Staphylococcus aureus strains that has been
associated with the multisystem illness toxic shock syndrome (TSS) (reviewed in
references 3-5). Most of the clinical, laboratory, and pathologic abnormalities
observed during the course of toxic shock syndrome are similar in many respects
to endotoxin shock (5-7). Moreover, animal studies have shown that, in common
with other staphylococcal and streptococcal exotoxins, TSST-1 has the capacity
to sensitize the host to lethal injury by small amounts of endotoxin (2, 7-9). It
hasbeen hypothesized that this interaction may be important in the pathogenesis
ofTSS (9, 10). Many features of the disease are as yet unexplained, and a better
understanding of the mechanisms involved in the response to TSST-1 would
allow us to test the efficacy oftherapeutic modalities.
Many studies have been directed at elucidating host mediator activation in
endotoxic shock. The role of cachectin was suggested by experiments in which
mice passively immunized against the factor were protected from the lethal effect
ofendotoxin (11). Cachectin and tumor necrosis factor (TNF), both produced
by activated macrophages, have then appeared as the same molecule (12). Like
endotoxin, TSST-1 is a potent inducer of IL-1 production by monocytes/
macrophages (13, 14), and IL-1 may in turn be responsible for the fever and for
some other features of TSS. Here we report that TSST-1 could also stimulate
human monocytes to produce TNF. Since TSST-1 is mitogenic for T cells (15,
16) and induces IL-2 production (17), we have evaluated its ability to stimulate
human peripheral lymphocytes by determining lymphotoxin and IFN-y produc-
tion, endogenous mediators that could play a role in many pathophysiological
processes, either alone or in synergism with other cytokines.
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'Abbreviations used in this paper:
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LAF, lymphocyte-activating factor; LT, lymphotoxin; MTT,
3(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide; rHu, recombinant human; rMu, recom-
binant murine; TSS, toxic shock syndrome; TSST-1, toxicshock syndrome toxin 1.
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Materials and Methods
Purified TSST-1.
￿
The toxin was purified to apparent homogeneity from an 18-h culture
of S. aureus FRI 1169 strain according to Schlievert et al. (7) with some modifications
(Anderson, S., and J. E. Alouf, manuscript submitted for publication). The homogeneity
of TSST-1 preparation was assessed by SDS-PAGE (silver staining), immunoprecipitation,
and immunoblotting by using a specific antiserum kindly provided by Dr. J . Iandolo
(Kansas State University, Manhattan, KS). 1 ng of toxin is equivalent to 10' nmol. The
lyophilized TSST-1 was dissolved in pyrogen-free saline, divided into working samples,
and stored at -20'C until used. Purified TSST-1 contained <20 ng LPS/mg protein, as
determined by a standard Limulus amebocyte lysate assay (M.A. Bioproducts, Walkersville,
MD).
Reagents.
￿
LPS from Salmonella enteritidis was obtained from Difco Laboratories Inc.
(Detroit, MI). PHA was purchased from Wellcome Laboratories (Beckenham, England).
PMA-, 3(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide (MTT), crystal violet,
and actinomycin D were obtained from Sigma Chemical Co. (St. Louis, MO). Nonspecific
esterase staining kit was purchased from Technicon Chemicals (Domont, France). Recom-
binant human TNF (rHuTNF) used to standardize the cytotoxic assay was kindly provided
by Biogen (Geneva, Switzerland) and Knoll A .G. (Ludwigshafen, Federal Republic of
Germany). Rabbit antisera raised to rHuTNF or to recombinant murine TNF (rMuTNF)
were generous gifts from Professor W. Fiers (State University of Ghent, Belgium) and
Dr. J. Tavernier (Biogent, Ghent, Belgium). Their respective neutralizing capacity was
assessed as 5 X 106 U/ml for rHuTNF and 3 .2 X 10' U/ml for rMuTNF.
Human Peripheral Blood Leukocytes (PBL) Populations.
￿
Buffy coats from adult healthy
volunteers were obtained from the Centre de Transfusion Sanguine (Hopital Pasteur,
Paris, France) through the courtesy of Dr. Dighiero. Mononuclear cells were isolated by
density centrifugation (Lymphoprep; Nyegaard, Oslo, Norway). They were seeded in 24-
well culture plates (F 3047; Falcon Labware, Oxnard, CA) at 2 X 106/ml nonspecific
esterase-positive cellsin complete serum-free medium consisting of RPMI 1640 (Seromed,
Berlin, FRG), antibiotics, 2 MM L-glutamine, and 0.01 M Hepes (Seromed). After
adherence for 2 h, nonadherent lymphocytes were removed by washing the wells twice
with medium . Adherent mononuclear cells were then cultured in fresh serum-free
complete medium overnight at 37'C (5% C02 in air) in the presence of various concen-
trations of stimulants. The supernatant fluids were collected, centrifuged, and stored at
-20'C until use. Nonadherent mononuclear cells were obtained after adherence for 2 h
to plastic flasks (F 3024, Falcon Labware) of total mononuclear cells (10'/ml). The
nonadherent cell preparation contained <5% nonspecific esterase-positive cells. They
were cultured overnight in 24-well culture plates (F 3072, Falcon Labware) at 6 X 106/
ml/well in medium supplemented with 5% FCS (Irvine Scientific, Santa Ana, CA) and in
the presence of the various stimulants. The cell-free supernatant fluids were then stored
at -200 C.
Cytotoxicity Assay.
￿
Cytotoxic activity in supernatant fluids was measured on mouse
L929a cells treated with actinomycin D, essentially as described by Ruffand Gifford (18).
Cells were seeded into flat-bottomed 96-well microtiter plates at 1 .25 X 10' per well in
RPMI with 5% FCS. The next day, threefold serial dilutions of the test samples were
applied in triplicate to the cells with a final concentration of 1 ug/ml actinomycin D. They
were further incubated at 37'C for 24 h. The culture medium was removed by inverting
and flicking the plate. The remaining adherent cells were stained for 15 min with a
solution of 15% methanol with 0.5% crystal violet. The plates were then washed and the
remaining dye was solubilized with SDS (1 %) for 15 min. Absorbance was read at 550 nm
with a microplate spectrophotometer (Titertek Multiscan; Flow Laboratories, Helsinki,
Finland). The cytotoxic activity (in units per milliliter) was defined as the reciprocal of
the dilution resulting in 50% cytotoxicity determined by plotting the regression line of
log of the dilution against absorbance.
Neutralization of TNF.
￿
Antibody neutralization was performed by incubation for 1 h
at 37'C of 1 :2,500 dilution of rabbit serum with pretested human supernatant fluids that
had been adjusted to ^-40 U/ml of cytotoxic activity. Lytic activity of the samples was754
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then determined in the microplate assay using twofold dilutions. Three rabbit sera were
comparatively used: a preimmune serum, and two immune sera, one specific for rHuTNF
and the other for rMuTNF.
IL-1 Assay.
￿
IL-1 production was quantitated in a lymphocyte activation (LAF) assay
using thymocytes from 8-wk-old C3H/Hej mice cultured in the presence of PHA (19).
IL-2 Assay.
￿
The IL-2 content in supernatant fluids was determined by incubating an
IL-2-dependent T cell line (CTLL2) at 104 cells/well with twofold dilutions of the test
sample for 24 h at 37°C . At the end of the assay the viability of the cells was evaluated
using the MTT assay (20). The potency of IL-2 is expressed in terms of reference units
of bioactivity based on the National Institutes of Health reference reagent supplied by
the Biological Response Modifiers Program of the National Cancer Institute (21).
IFN-y Assay.
￿
Interferon was quantified as the reciprocal of the dilution that produced
a 50% reduction in vesicular stomatitis virus-induced lysis of human amniotic WISH cells
(22) as compared with a standard preparation of rIFN-y of 2 X 10' U/mg (RU 42369;
Roussel-Uclaf, Romainville, France). Its species specificity was characterized by substitut-
ing rat fibroblasts for human WISH cells in the assay and by determining its inhibition by
mAbs to IFN-y (Centocor, Malvern, PA).
Results
Stimulation ofHuman Monocytes with TSST-1.
￿
Human peripheral blood mono-
cytes isolated under LPS-free conditions were cultured for 20 h with varying
concentrations of TSST-1 in a serum-free medium. Unstimulated monocytes
from any of the donors did not produce detectable levels of TNF activity, as
assayed on actinomycin D-treated L929a cells. Treatment of monocyte cultures
with TSST-1 resulted in the production of significant titers of TNF activity,
even for as low as 10 or 100 pg/ml. By itself, the toxin had no direct toxic effect
on the target cells. In a typical assay presented in Fig. 1 A, the level of cytotoxicity
increased in a dose-dependent manner. Cells from 10 different donors were
exposed to several concentrations of TSST-1 in comparable experiments . In all
assays, a significant titer of TNF activity was induced by TSST-1, but some of
the donor cells (2 of 10) were more responsive to the toxin. Moreover, the peak
of the response varied between 1 ng/ml to 1 Fig/ml of TSST-1, depending on
the donor. With 10 ng/ml of TSST-1 (Fig. I B), the mean level of cytotoxic
activity found in cell cultures from the 10 donors (67.3 U/ml) corresponds to a
concentration of 3 .6 ng/ml of rHuTNF used as control in the assay .
A higher dispersion in the cytotoxic activity level was still observed when
monocytes from the same donors were stimulated with two to four different
concentrations of LPS used as control. In terms of TNF activity, two types of
responses were determined; thus with 100 ng/ml LPS in cell cultures from six
of the donors the mean titer was 48 ± 22.6 U/ml, whereas it ranged from 250
to 2,150 U/ml in cell cultures from the four other donors (data not shown) . It is
worth noting that high responders to LPS were not those producing higher levels
of TNF activity in response to TSST-1 .
IL-1 activity was estimated in some of the supernatant fluids by the LAF assay.
As expected, TSST-1 induced the release of IL-1 from human monocytes (13,
14) . Due to the high degree of proliferation caused by TSST-1 alone added to
the mouse thymocytes, its direct effect should be subtracted. Under these
conditions, the addition of supernatant fluids from monocytes cultured for 20 h
in the presence of TSST-1 dramatically enhanced proliferation . A high level of
IL-1 activity could be demonstrated with low dosage level of TSST-1, i .e., at IUim I
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TABLE I
Human Lymphocyte Responses Induced with TSST-1 Toxin
Cyrokine activity in cultures incubated with:
Uiml
120
100
80
-60
"40
" 20
0
￿
0
￿
1
￿
10
￿
180
￿
1000 ng/mll'O ng/ml
TSST-1
FIGURE 1 .
￿
Cytotoxic activity (U/ml) on actinomycin D-treated L929a cells in supernatant
fluids from 2 x 10`/ml human monocytes incubated for 20 h with TSST-1 in a serum-free
medium . (A) Dose response to TSST-1 in cell culture from one donor; (B) variations in the
response to 10 ng/ml TSST-1 in cell cultures from 10 different individuals .
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Cyrokinecontent was determined in supernatant fluids of 6 x 106/nil lymphocytes from two donors incubated with different inducers
(dose/nil) for 24 It .
and 10 ng/ml (data not shown) . There was no IFN activity detectable in these
monocyte cultures .
Stimulation of Human Lymphocytes with TSST-1 .
￿
Enriched preparations of
freshly isolated lymphocytes (nonadherent cells containing <5% nonspecific
esterase-positive cells) were cultured for 20 h with the various inducers . In the
same cell-free supernatant fluids, the cytotoxic activity on L929a cells, IL-2 and
IFN-y levels were determined . Two representative experiments are reported in
Table 1, but several partial assays have shown that the results are reproducible .
Exp. Assay
Nothing
PHA
(5 tag)
PMA
(20 ng)
1 .PS
(10 ng) 0 .1
TSST-1 toxin
1 10
(ng)
100 1,000
U/tnl L'/ml
A Cytotoxicity 1.929 cells <3 150 786 - 56 109 77 63 39
1 FN-y <2 2,990 570 - NT 1,375 1,470 2,125 3,250
IL-2 0 89 3 - 82 118 120 123 113
B Cvtotoxicity 1.929 cells <3 40 256 21 74 171 103 85 29
IFN-7 <2 1,7511 595 80 1,220 1,430 1,930 2,000 2,750
11.2 3 20 1 0 75 176 176 136 127756
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Cytotoxic activity for L929a cells was produced by nonadherent mononuclear
cells incubated with the toxin and the titer peaked for a low dose of TSST-1 (1
ng/ml) . IFN-y titers obtained after exposing nonadherent cells to TSST-1 were
comparable to those induced by PHA, the highest dose of toxin used in the assay
(1 ug/ml) being more potent than 5 Ag/ml PHA. Under these conditions, the
production of IFN-y was lower in lymphocyte cultures stimulated with the
phorbol ester at 20 ng/ml (Table I) . An increased production of IL-2 was also
found as already reported by other investigators (17) . No clear dose-dependent
response was observed with the doses of toxin used in the assay . A single dose of
PHA, PMA, or LPS was used in control cultures . The level of responses to these
inducers did not show any correlation with the titers obtained in cultures
stimulated with TSST-1 .
Costimulation with PMA of mitogen-activated human lymphocytes synergisti-
cally enhances cytokine production (23, 24). Such a response was obtained in
our assays depicted in Fig . 2 . The cytotoxic activity, IFN-y and IL-2 levels were
strongly potentiated in cell cultures stimulated with PHA plus PMA. Although
to a lesser extent, responses to TSST-l were also markedly increased by the
addition of PMA . Thus, costimulation with PMA and TSST-l (100 ng/ml)
resulted in a greater than threefold increase in both cytotoxic activity or IFN-y
level over those observed after treatment with each inducer separately, and a
greater than eightfold increase in IL-2 level (Fig. 2) .
FIGURE 2 .
￿
Cytokine production by nonadherent human PBL (6 x 10''/ml) cultured for 20
h in the presence o£ PMA plus TSST-I or PHA . Cell-free supernatants were collected and
tested for cytotoxic activity on actinomycin D-treated L929a cells, and for IFN--Y and IL-2
content . The open bars represent values obtained in the presence of PMA, while the shaded
parts correspond to control cultures with the respective stimulant (/, medium ; M, PHA; M,
TSST) in the absence ofPMA. The results depicted in the figure are representative of three
identical experiments .JUPIN ET AL.
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TABLE lI
Cytotoxic Activity on L929 Cells in Supernatant FluidsfromHuman PBL after Treatment with
Rabbit anti-rHuTNF-specific Antiserum
Discussion
Supernatant fluids from PBL collected as describedwere pretested for cytotoxic activity and adjusted
to 20-50 U/ml before being incubated for 1 h at 37°C with the indicated rabbit serum at 1 :2,500
dilution . Thedata are representative of three separate assays .
Effect of Neutralizing Antibody to rHuTNF on TSST-1-induced Cytotoxic Activ-
ity. The cytotoxic activity on L929a cells found in both monocyte and lympho-
cyte supernatant fluids was further characterized in neutralization experiments
using a polyclonal antiserum directed against rHuTNF that did not react with
lymphotoxin . When these antibodies were added to supernatant from monocyte
cultures stimulated either with TSST-1 or LPS, a complete inactivation of the
cytotoxic effect was obtained, whereas control normal or immune sera were
ineffective (Table II) . When nonadherent cells were cultured in the presence of
TSST-1, most of the cytotoxic activity found in the supernatant fluids was not
affected by treatment with antibody directed to rHuTNF, suggesting that lym-
photoxin (LT or TNF-a) was the major cytotoxin produced . However, co-
stimulation with PMA, which potentiated the production of cytotoxic activity by
the two mitogens, TSST-1 or PHA, modified the relative level of the two
cytotoxins secreted in lymphocyte preparations since a greater inhibition of
cytocidal activity was found after addition of rHuTNF antibodies to the super-
natant fluids (Table 11) . Mitogenic lectins, alone or synergistically with phorbol
ester, have already been reported as efficient inducers of TNF production by
highly purified human lymphocytes (25) .
In addition to LPS or Gram-negative bacteria, other microorganisms or their
components were found to induce the production of cytotoxic factor(s) by
monocytes/macrophages (23, 26-28) . In this study, staphylococcal TSST-1 was
demonstrated as a potent inducer of TNF production by human blood mono-
Cytotoxic sample
source
Inducer in PBL cultures
(dose/ml)
Cytotoxicity (U/ml)
Nothing Anti-
rHuTNF
after
Pre-
im-
mune
treatment
Anti-
rMuTNF
Adherent cells Medium 0 0 0 0
TSST-1 (1 ng) 35 0 38 36
TSST-1 (10 ng) 39 0 43 37
LPS (10 ng) 28 0 27 30
Nonadherent cells Medium 0 0 0 0
TSST-1 (10 ng) 28 21 31 29
TSST-1 (100 ng) 34 23 33 35
TSST-1 (10 ng)+PMA 45 13 43 40
TSST-1 (100 ng) +PMA 43 12 43 45
PHA (5 fag) +PMA 28 9 28 29
rHuTNF solution - 44 0 47 37
rMuTNF solution - 38 37 42 075 8
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cytes . It has already been reported that TSST-1 could stimulate human mono-
cytes to release large quantities of IL-1 (13, 14) . A significant production of both
IL-1 and TNF was achieved by stimulating the cells with very low amounts of
TSST-1 (0 .1 or 1 ng/ml), showing that the toxin was an inducer still more
efficient than LPS. The TNF activity produced by adherent mononuclear cells
was completely neutralized by a polyclonal antibody prepared againstrHuTNF .
Our results do not support unpublished data mentioned by Beutler and Cerami
(29) indicating that TSST-1 was incapable of eliciting cachectin/TNF biosyn-
thesis . Different experimental conditions could perhaps explain the discrepancy .
Since the monocyte population used in this study was not pure, it remains that
some cells other than monocytes may be required for TNF production . Addi-
tional experiments have shown that a human promyelocytic cell line could be
stimulated with TSST-1 to produceTNF activity (De Azavedo, J . C ., unpublished
results), showing that TNF induction by TSST-1 could be established without
the influence of other cell types .
The staphylococcal toxin could also stimulate other cell population(s) among
human blood mononuclear cells . TSST-1 is known to induce proliferative re-
sponse of T cells functioning as a nonspecific mitogen (16, 17) . The present
study shows that after exposure to TSST-1, nonadherent cells could produce
several cytokine activities, namely cytotoxic factors, IL-2, and IFN-.y . The
cytotoxic activity found in lymphocyte preparations stimulated with TSST-1
could be partly related to TNF production as indicated by a slight inhibition
with anti-rHuTNF . Whether or not it is related to the presence of contaminant
monocytes remains to be determined, but low levels ofTNF can be produced by
T cells upon mitogen stimulation (23, 24) . Nevertheless, the remaining cytotoxic
activity observed after addition of anti-rHuTNF antibodies indicates that the
predominant source of cytotoxin is probably lymphotoxin . Higher levels ofTNF
were still produced when lymphocyte preparations were stimulated in the pres-
ence ofPMA as has been demonstrated with other mitogens (23, 25) . A possible
role of IFN--y in the cytotoxic activity of both TNF and LT contained in
nonadherent cell cultures cannot be excluded in this report . Regarding the
release of IL-2 and IFN--y, TSST-1 was found to be more efficient than PHA or
PMA used as positive controls in the assay . However, in combination with PMA,
the staphylococcal toxin appeared less potent than PHA, although it displayed a
synergistic effect .
The significance of the cytokine production in the pathophysiological mecha-
nisms of TSS has still to be determined in a suitable animal model . TSS is a
syndrome with some clinical features that are not generally seen in the shock
caused by endotoxin-producing bacteria . The production of TNF has been
suspected to be an important mediator of endotoxicity (29), and the pathophys-
iological effects elicited by intravenous injection of purified rTNF into mice or
rats could not be distinguished from those produced by endotoxin (30, 31) .
Moreover, treatment that increased the mouse sensitivity to the lethal effect of
LPS also enhanced the toxicity ofTNF, e.g ., in galactosamine-treated mice (32)
or in adrenalectomized mice (Parant, M ., unpublished results) . TSST-1, like
LPS, is capable of activating human monocytes to produce TNF and IL-1 .
However, unlike LPS, the toxin also has an effect on cytokine production byJUPIN ET AL.
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lymphocytes. It is possible that lymphotoxin, a molecule that is similar in several
aspects to TNF, plays a comparable role in inflammatory disease states (30, 31,
33). In addition, there are many examples of synergism between TNF or LT
and IFN-y, even if toxicity of a combined treatment has not been evaluated yet.
Thus, IFN-y wasshown to permit the LPS-inducedproduction ofTNF/cachectin
by C3H/HeJ (LPS-resistant) macrophages (34). Moreover, mutual stimulatory
interactions that occur with these different cytokines may be responsible for
pathophysiological mechanisms distinct from shock caused by LPS. Differences
in in vitro responses to TSST-1 in variousanimal models could provide pertinent
information in relation to great variations in animal susceptibility to TSS.
Summary
We present evidence that toxic shock syndrome toxin 1 (TSST-1) induces the
production of high levels of TNF by human blood monocytes. Enriched lympho-
cyte preparations incubated with the staphylococcal toxin produced significant
levels of TNF-like activity that is not neutralized by anti-rHuTNF antibodies and
is likely to be lymphotoxin (LT or TNF-,B). We demonstrate also that TSST-1 is
a potent inducer of IFN-y. When lymphocyte preparations were costimulated
with PMA, the TSST-1 effect was strongly potentiated and the levels of cytotoxic
factors, IFN-y, and IL-2 present in supernatant fluids were comparable to those
observed after treatment with PMA and PHA. Thus, TSST-1, which is also
known as an inducer of IL-1 and IL-2, stimulates the production of endogenous
mediators that could play a role in the physiopathological processes of toxic
shock syndrome (TSS). The described results suggest that the discrepancies in
the clinical features between TSS and endotoxin shock may be related to
qualitative differences in cytokine production.
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